Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

58 Press Releases
DateTitleCompany
20 Mar 15 Lilly and Innovent Biologics Announce a Strategic Alliance to Bring Potential Oncology Therapies to Patients in China and Around the World ELI LILLY AND COMPANY - LAUREN ZIERKE,
Published by
PR Newswire
19 Mar 15 Lilly and Hanmi Announce an Exclusive License and Collaboration Agreement for the Development and Commercialization of an Immunological Therapy ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
04 Mar 15 Lilly and IU School of Medicine Partner on Rotation Program for Medical Students ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
06 Feb 15 Lilly to Present at Leerink Global Healthcare Conference ELI LILLY AND COMPANY - LAUREN ZIERKE,
Published by
PR Newswire
05 Jan 15 Lilly Announces Promotion of Darren J. Carroll to Senior Vice President of Corporate Business Development ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
01 Jan 15 Lilly Finalizes Novartis Animal Health Acquisition ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
01 Dec 14 Eli Lilly and Company and AstraZeneca Initiate Pivotal Clinical Trial for Patients with Early Alzheimer's Disease ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
29 Oct 14 Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
16 Sep 14 Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
13 Jul 14 New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
09 Jul 14 Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement ELI LILLY AND COMPANY - MARK TAYLOR,
Published by
PR Newswire
23 Jun 14 Eli Lilly and Company Collaborates with Public and Private Healthcare Organizations to Provide Medical Students an Opportunity to Explore Healthcare Outside the Traditional Learning Environment ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
17 Jun 14 Type 2 diabetes: Boehringer Ingelheim and Eli Lilly and Company announce resubmission of New Drug Application for empagliflozin to FDA ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
09 Jun 14 Lilly to Participate in Goldman Sachs Global Healthcare Conference ELI LILLY AND COMPANY - MARK TAYLOR,
Published by
PR Newswire
27 May 14 Lilly Announces Date for Investor Web Call; Plans To Share Phase III Dulaglutide Data ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
30 Apr 14 Covance and Lilly Honored with Alliance Excellence Award ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
25 Apr 14 Eli Lilly and Company Launches Second Education Program for Medical Students ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
09 Apr 14 Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
24 Feb 14 Elanco Announces Agreement to Acquire Lohmann Animal Health ELI LILLY AND COMPANY - MARK TAYLOR,
Published by
PR Newswire
08 Jul 13 Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
25 Jun 13 Trajenta® (linagliptin): New data on safety and efficacy in Type 2 Diabetes patients with moderate to severe renal impairment Boehringer Ingelheim and Eli Lilly and Company,
Published by
Ogilvy HealthPR London
25 Jun 13 New efficacy and safety data presented for Trajenta® (linagliptin) in Asians with Type 2 Diabetes Boehringer Ingelheim and Eli Lilly and Company,
Published by
Ogilvy HealthPR London
31 May 13 New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
20 May 13 From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
13 May 13 Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma Eli Lilly and Company
06 Mar 13 Lilly Sets Date for 2013 Diabetes Pipeline Update to the Media and Investment Community Eli Lilly and Company
08 Jan 13 Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin Boehringer Ingelheim and Eli Lilly and Company,
Published by
Boehringer Ingelheim
24 Oct 12 New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Eli Lilly and Company
02 Oct 12 Pooled analysis in adults with type 2 diabetes Eli Lilly and Company
30 Aug 12 Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results Eli Lilly and Company
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.